The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses-Population Based Analysis of 458 Patients Treated Between 2003-2009.
Authors | |
---|---|
Year of publication | 2010 |
Type | Conference abstract |
MU Faculty or unit | |
Citation |